Rhode Island General Laws 27-20-17. Mammograms and pap smears – Coverage mandated
(a) Subscribers to any nonprofit medical service plan shall be afforded coverage under the plan for mammograms and pap smears, in accordance with guidelines established by the American Cancer Society.
Terms Used In Rhode Island General Laws 27-20-17
- Nonprofit medical service plan: means a plan by which specified medical service is provided to subscribers to the plan by a nonprofit medical service corporation. See Rhode Island General Laws 27-20-1
- person: may be construed to extend to and include co-partnerships and bodies corporate and politic. See Rhode Island General Laws 43-3-6
- Subscribers: means those persons or groups of persons who contract with a nonprofit medical service corporation for medical service pursuant to a nonprofit medical service plan. See Rhode Island General Laws 27-20-1
(b) Notwithstanding the provisions of this chapter, subscribers to any nonprofit medical service plan shall be afforded coverage for two (2) paid screening mammograms per year when recommended by a physician for women who have been treated for breast cancer within the last five (5) years or who are at high risk of developing breast cancer due to genetic predisposition (BRCA gene mutation or multiple first-degree relatives) or high risk lesion on prior biopsy (lobular carcinoma in situ) or atypical ductal hyperplasia.
History of Section.
P.L. 1988, ch. 532, § 2; P.L. 2005, ch. 405, § 3.
§ 27-20-17. Mammograms and pap smears — Coverage mandated. [Effective January 1, 2024.]
(a) Subscribers to any nonprofit medical service plan shall be afforded coverage under the plan for mammograms and pap smears, in accordance with guidelines established by the American Cancer Society.
(b) Notwithstanding the provisions of this chapter, subscribers to any nonprofit medical service plan shall be afforded coverage for:
(1) Two (2) paid screening mammograms per year when recommended by a physician for women who have been treated for breast cancer within the last five (5) years or who are at high risk of developing breast cancer due to genetic predisposition (BRCA gene mutation or multiple first-degree relatives) or high risk lesion on prior biopsy (lobular carcinoma in situ) or atypical ductal hyperplasia; and
(2) Any screening deemed medically necessary for proper breast cancer screening in accordance with applicable American College of Radiology guidelines including, but not limited to, magnetic resonance imaging, ultrasound, or molecular breast imaging for any person who has received notice pursuant to § 23-12.9-2 of the existence of dense breast tissue.
History of Section.
P.L. 1988, ch. 532, § 2; P.L. 2005, ch. 405, § 3; P.L. 2023, ch. 331, § 3, effective January 1, 2024; P.L. 2023, ch. 332, § 3, effective January 1, 2024.